Table 4

Linear regressions of predictors of likelihood of using PreP in the next 6 months

n (%)Likelihood of future PrEP use, M (SD)UnadjustedAdjusted
b (95% CI)P values b (95% CI)P values
PEP use (last 12 months)n=9680
 Yes
 No
758 (7.8)
8922 (92.2)
3.87 (1.16)
2.85 (1.18)
1.02
(0.94 to 1.11)
<0.0010.48
(0.39 to 0.57)
<0.001
STI diagnosis (last 12 months)n=6289
 Yes
 No
1255 (20.0)
5034 (80.0)
3.31 (1.34)
2.86 (1.20)
0.45
(0.37 to 0.52)
<0.0010.16
(0.09 to 0.23)
<0.001
Chemsex (last 3 months)n=9146
 Yes
 No
620 (6.8)
8526 (93.2)
3.67 (1.25)
2.86 (1.19)
0.81
(0.71 to 0.90)
<0.0010.39
(0.30 to 0.49)
<0.001
Happy with sex life?n=9165
 Very unhappy
 Unhappy
 Not sure/don’t know
 Happy
 Very happy
438 (5.1)
1991 (22.1)
1649 (15.7)
3824 (42.4)
1263 (14.7)
2.66 (1.27)
2.82 (1.11)
2.88 (1.19)
2.97 (1.20)
3.06 (1.40)
0.09
(0.06 to 0.11)
<0.0010.03
(0.01 to 0.05)
0.003
  • Note: Adjusted analyses include age, country of residence (reference group=France) and current PrEP use as covariates. Participants who responded with ‘unsure’ to having an STI diagnosis were excluded from this analysis.

  • PEP, post-exposure prophylaxis; PrEP, pre-exposure prophylaxis.